RT Journal
A1 Moses III H, Dorsey E
T1 BIomedical research in an age of austerity
JF JAMA
JO JAMA
YR 2012
FD December 12
VO 308
IS 22
SP 2341
OP 2342
DO 10.1001/jama.2012.14846
UL http://dx.doi.org/10.1001/jama.2012.14846
AB 
The National Institutes of Health (NIH) budget would be reduced by $2.5 billion, or about 8.2%.1 Given that three-fourths of the NIH budget is committed to previously awarded grants, sequestration could affect predominantly new applications and young researchers. These budget reductions at the NIH and at other research agencies, such as $0.5 billion at the Centers for Disease Control and Prevention and $0.6 billion at the National Science Foundation (Table), will exacerbate tensions between large infrastructure projects (such as those that maintain public databases in genomics, clinical trials, and bioinformatics) and small investigator-initiated grants, which historically have been the primary source of new clinical insights.